SETD1B and acute myeloid leukemia: While the presence of FLT3-ITD mutation does not correlate with the expression of SETD1B transcription in AML patients, FLT3-ITD may promote SETD1B catalytic activity through cell signaling pathways, including the Ras signaling pathway.